The effect of dihydroceramide desaturase 1 inhibition on endothelial impairment induced by indoxyl sulfate-Reference-Cited by-同舟云学术

The effect of dihydroceramide desaturase 1 inhibition on endothelial impairment induced by indoxyl sulfate

Published:2021-12 Issue: Volume:141 Page:106923
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Savira Feby,Kompa Andrew R.,Kelly Darren J.,Magaye Ruth,Xiong Xin,Huang Li,Liew Danny,Reid Christopher,Kaye David,Scullino Carmen V.,Pitson Stuart M.,Flynn Bernard L.,Wang Bing H.

Funder

NHMRC

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference47 articles.

1. Vascular and cardiac remodeling in end-stage renal disease;London;Nefrologia,1997

2. Cardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management;Pateinakis;Int. J. Nephrol.,2011

3. Characterization of endothelial and smooth muscle cells from different canine vessels;Oosterhoff;Front. Physiol.,2019

4. The role of dihydrosphingolipids in disease;Magaye;Cell. Mol. Life Sci.,2019

5. Sphingolipid regulation of tissue fibrosis;Shea;Open Rheumatol. J.,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of function and reduced levels of sphingolipid desaturase DEGS1 variants are both relevant in disease mechanism;Journal of Lipid Research;2024-03

2. Mysterious sphingolipids: metabolic interrelationships at the center of pathophysiology;Frontiers in Physiology;2024-01-03

3. Potential Drug Targets for Ceramide Metabolism in Cardiovascular Disease;Journal of Cardiovascular Development and Disease;2022-12-02

4. Involvement of Ceramide Metabolism in Cerebral Ischemia;Frontiers in Molecular Biosciences;2022-04-20